Polytheragene has specific know-how in the synthesis of polymers for biology. Polytheragene develops and commercializes polymers for the transfer of nucleic acids and of hydrophobic active molecules

The company targets companies involved in the bioproduction of proteins and recombinant viral particles, screening platforms and research laboratories.

Polytheragene is involved in gene therapy and mRNA-based therapies.